MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617055356 A) filed by Veru, Inc. on April 30, 2026, for Uses Of Selective Androgen Receptor Modulator (sarm) Compounds In Chronic Weight Management.
Inventors include Steiner, Mitchell S.; and Barnette, Kester Gary.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present invention provides methods and compositions for preventing, reducing, or treating adverse effects caused by an incretin agonist or antagonist containing weight loss drug or a sodium-glucose transport protein 2 (SGLT-2) inhibitor in a subject who is under treatment with the incretin agonist or antagonist containing weight loss drug or SGLT-2 inhibitor. The method comprises coadministering or administering after discontinuation of the incretin agonist or antagonist containing weight loss drug or SGLT-2 inhibitor to the subject a therapeutically effective amount of a selective androgen receptor modulator (SARM) compound represented by a structure of Formulas I, II, VIII, IX, X, XI, XII, XIII, and XIV disclosed herein to the subject under incretin agonist or antagonist containing drug or SGLT-2 agent therapy.
Disclaimer: Curated by HT Syndication.
